SynBioBeta Speaker

Bharath Takulapalli

SPOC Biosciences

CEO & Founder

Bharath Takulapalli is the Founder and CEO of SPOC Biosciences, a deep-tech company pioneering on-chip drug discovery for the AI era. SPOC is a category-defining platform that combines high-throughput on-chip synthesis of protein or drug variant libraries, high-resolution analysis and multiplexed molecular profiling to enable biologics discovery at unprecedented scale and fidelity.Bharath envisions the SPOC platform driving a generational shift beyond 50+ years of microwell plate-based workflows toward a new paradigm of on-chip synthesis, discovery and development, serving both traditional drug development and AI-driven therapeutic design.His work sits at the intersection of systems biology, molecular biophysics, nanotechnology and engineering. He is the principal inventor behind SPOC’s core technology and has led the company from inception through the development of SPOC as a foundational life sciences platform focused on advancing therapeutic discovery. Bharath holds a PhD from Arizona State University and a BTech from IIT Madras.

Sessions Featuring

Bharath

This Year

Lightning Talk

•

11:22 AM

-

11:26 AM

Tools & Tech

SPOC: Driving a New Era of On-Chip Drug Discovery — Beyond 50+ Years of Microwell Plates

For more than 50 years, drug discovery has relied on microwell plate-based workflows. In this talk, Bharath Takulapalli will outline his vision for a new paradigm: on-chip drug discovery for the AI era. He will share how SPOC is building a platform that integrates high-throughput on-chip protein synthesis, high-resolution binding analysis and direct on-chip assessment of developability to make therapeutic discovery faster, more scalable and more data-rich, with the goal of reducing lead attrition and downstream clinical failure. The talk will explore how this transition could reshape both traditional biologics discovery and AI-driven therapeutic design, moving the industry beyond fragmented microwell plate-based experimental workflows into a new era of integrated, scalable on-chip discovery and development grounded in rich molecular data.

Featuring

Bharath Takulapalli

SPOC Biosciences

CEO & Founder

Lightning Talk

•

11:22 AM

-

11:26 AM

Tools & Tech

SPOC: Driving a New Era of On-Chip Drug Discovery — Beyond 50+ Years of Microwell Plates

For more than 50 years, drug discovery has relied on microwell plate-based workflows. In this talk, Bharath Takulapalli will outline his vision for a new paradigm: on-chip drug discovery for the AI era. He will share how SPOC is building a platform that integrates high-throughput on-chip protein synthesis, high-resolution binding analysis and direct on-chip assessment of developability to make therapeutic discovery faster, more scalable and more data-rich, with the goal of reducing lead attrition and downstream clinical failure. The talk will explore how this transition could reshape both traditional biologics discovery and AI-driven therapeutic design, moving the industry beyond fragmented microwell plate-based experimental workflows into a new era of integrated, scalable on-chip discovery and development grounded in rich molecular data.

Featuring

Bharath Takulapalli

SPOC Biosciences

CEO & Founder

Previous Speakers Include